Literature DB >> 24586080

Survivorship: sexual dysfunction (female), version 1.2013.

Crystal S Denlinger, Robert W Carlson, Madhuri Are, K Scott Baker, Elizabeth Davis, Stephen B Edge, Debra L Friedman, Mindy Goldman, Lee Jones, Allison King, Elizabeth Kvale, Terry S Langbaum, Jennifer A Ligibel, Mary S McCabe, Kevin T McVary, Michelle Melisko, Jose G Montoya, Kathi Mooney, Mary Ann Morgan, Tracey O'Connor, Electra D Paskett, Muhammad Raza, Karen L Syrjala, Susan G Urba, Mark T Wakabayashi, Phyllis Zee, Nicole McMillian, Deborah Freedman-Cass.   

Abstract

Cancer treatment, especially hormonal therapy and therapy directed toward the pelvis, can contribute to sexual problems, as can depression and anxiety, which are common in cancer survivors. Thus, sexual dysfunction is common in survivors and can cause increased distress and have a significant negative impact on quality of life. This section of the NCCN Guidelines for Survivorship provides screening, evaluation, and treatment recommendations for female sexual problems, including those related to sexual desire, arousal, orgasm, and pain.

Entities:  

Mesh:

Year:  2014        PMID: 24586080      PMCID: PMC4465262          DOI: 10.6004/jnccn.2014.0019

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN: 1540-1405            Impact factor:   11.908


  54 in total

1.  Influence of PDE5 inhibitor on MRI measurement of clitoral volume response in women with FSAD: a feasibility study of a potential technique for evaluating drug response.

Authors:  C C Yang; Y Y Cao; Q Y Guan; J R Heiman; S W Kuffel; B T Peterson; K R Maravilla
Journal:  Int J Impot Res       Date:  2007-12-06       Impact factor: 2.896

2.  Sexual morbidity in very long term survivors of vaginal and cervical cancer: a comparison to national norms.

Authors:  Stacy Tessler Lindau; Natalia Gavrilova; Diane Anderson
Journal:  Gynecol Oncol       Date:  2007-06-20       Impact factor: 5.482

3.  Sildenafil in women with sexual arousal disorder following spinal cord injury.

Authors:  M S Alexander; R C Rosen; S Steinberg; T Symonds; S Haughie; C Hultling
Journal:  Spinal Cord       Date:  2010-08-24       Impact factor: 2.772

4.  Sildenafil improves sexual functioning in premenopausal women with type 1 diabetes who are affected by sexual arousal disorder: a double-blind, crossover, placebo-controlled pilot study.

Authors:  Salvatore Caruso; Salvatore Rugolo; Carmela Agnello; Giorgia Intelisano; Lucia Di Mari; Antonio Cianci
Journal:  Fertil Steril       Date:  2006-03-31       Impact factor: 7.329

5.  Sexual function changes during the 5 years after high-dose treatment and hematopoietic cell transplantation for malignancy, with case-matched controls at 5 years.

Authors:  Karen L Syrjala; Brenda F Kurland; Janet R Abrams; Jean E Sanders; Julia R Heiman
Journal:  Blood       Date:  2007-09-18       Impact factor: 22.113

Review 6.  Erectile dysfunction and cardiovascular disease: efficacy and safety of phosphodiesterase type 5 inhibitors in men with both conditions.

Authors:  Ajay Nehra
Journal:  Mayo Clin Proc       Date:  2009-02       Impact factor: 7.616

7.  Effect of sildenafil on clitoral blood flow and sexual response in postmenopausal women with orgasmic dysfunction.

Authors:  Ana L Cavalcanti; Vicente R Bagnoli; Angela M Fonseca; Roberto A Pastore; Eduardo B Cardoso; Jucilene S Paixão; José M Soares; Fabrício Saad; Edmund C Baracat
Journal:  Int J Gynaecol Obstet       Date:  2008-06-26       Impact factor: 3.561

8.  Quality of life and sexual problems in disease-free survivors of cervical cancer compared with the general population.

Authors:  Sang Yoon Park; Duk-Soo Bae; Joo Hyun Nam; Chong Taik Park; Chi-Heum Cho; Jong Min Lee; Myung Kyung Lee; Soo Hyun Kim; Sang Min Park; Young Ho Yun
Journal:  Cancer       Date:  2007-12-15       Impact factor: 6.860

Review 9.  Interventions for sexual dysfunction following treatments for cancer.

Authors:  C L Miles; B Candy; L Jones; R Williams; A Tookman; M King
Journal:  Cochrane Database Syst Rev       Date:  2007-10-17

10.  Interventions for sexuality after pelvic radiation therapy and gynecological cancer.

Authors:  Anne Katz
Journal:  Cancer J       Date:  2009 Jan-Feb       Impact factor: 3.360

View more
  6 in total

1.  National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: V. The 2014 Ancillary Therapy and Supportive Care Working Group Report.

Authors:  Paul A Carpenter; Carrie L Kitko; Sharon Elad; Mary E D Flowers; Juan C Gea-Banacloche; Jörg P Halter; Flora Hoodin; Laura Johnston; Anita Lawitschka; George B McDonald; Anthony W Opipari; Bipin N Savani; Kirk R Schultz; Sean R Smith; Karen L Syrjala; Nathaniel Treister; Georgia B Vogelsang; Kirsten M Williams; Steven Z Pavletic; Paul J Martin; Stephanie J Lee; Daniel R Couriel
Journal:  Biol Blood Marrow Transplant       Date:  2015-03-31       Impact factor: 5.742

Review 2.  Sexual dysfunction in women with cancer: a systematic review with meta-analysis of studies using the Female Sexual Function Index.

Authors:  Maria Ida Maiorino; Paolo Chiodini; Giuseppe Bellastella; Dario Giugliano; Katherine Esposito
Journal:  Endocrine       Date:  2015-12-07       Impact factor: 3.633

3.  Female Sexual Health Training for Oncology Providers: New Applications.

Authors:  Lynn Y Wang; Annette Pierdomenico; Abbe Lefkowitz; Rachael Brandt
Journal:  Sex Med       Date:  2015-04-14       Impact factor: 2.491

Review 4.  Prevalence of sexual dysfunction in women with cancer: A systematic review and meta-analysis.

Authors:  Seyedeh Esmat Hosseini; Mahnaz Ilkhani; Camelia Rohani; Alireza Nikbakht Nasrabadi; Raza Ghanei Gheshlagh; Ashraf Moini
Journal:  Int J Reprod Biomed       Date:  2022-02-18

Review 5.  Opioid-Induced Sexual Dysfunction in Cancer Patients.

Authors:  Bartłomiej Salata; Agnieszka Kluczna; Tomasz Dzierżanowski
Journal:  Cancers (Basel)       Date:  2022-08-22       Impact factor: 6.575

Review 6.  Emotional and sexual concerns in women undergoing pelvic surgery and associated treatment for gynecologic cancer.

Authors:  Cara Stabile; Abigail Gunn; Yukio Sonoda; Jeanne Carter
Journal:  Transl Androl Urol       Date:  2015-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.